Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director

Page created by Lonnie Baldwin
 
CONTINUE READING
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
Glanbia plc
Q3 2021
10 November 2021

Group Managing Director   Group Finance Director
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
2
Glanbia plc | Quarter 3 2021 presentation

Important notice

This presentation contains forward-looking statements. These statements have
been made by the Directors in good faith based on the information available to
them up to the time of their approval of this presentation.
Due to the inherent uncertainties, including both economic and business risk
factors underlying such forward-looking information, actual results may differ
materially from those expressed or implied by these forward-looking statements.
The Directors undertake no obligation to update any forward-looking statements
contained in this presentation, whether as a result of new information, future
events, or otherwise.
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
3
Glanbia plc | Quarter 3 2021 presentation

Q3 2021 Results summary

                                 Glanbia delivers strong Q3 YTD; wholly-owned revenue +15.7% cc

                                 GPN LFL Branded revenue +25.2% cc

                                 GN Nutritional Solutions volume +15.7% cc

                                 Strong cash conversion, net debt reduced by €39 million to
                                 €589 million

                                 Announcing proposed sale of PLC’s 40% shareholding in
                                 Glanbia Ireland to Glanbia Co-op for €307 million
“cc” denotes constant currency
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
4
Glanbia plc | Quarter 3 2021 presentation

2021 Strategic update and outlook

              On schedule for targeted results                    Acquired PacMoore, in NS, for $52 million         Maintain supply chain delivery

 Delivering revenue growth and efficiencies                          Completed second share buyback                     Manage cost inflation
                                                                  returning €100 million in past 12 months

                                   2021 Adjusted EPS, constant currency, growth expected to be
                                            at the upper end of the 17% to 22% range                          Maintain our strong financial position
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
5
Glanbia plc | Quarter 3 2021 presentation

Proposed sale of PLC stake in Glanbia Ireland

Description                                 Strategic rationale                     Transaction details

Glanbia has signed a memorandum of          Enables both shareholders to focus      Selling price €307 million
understanding with Glanbia Co-op to         on their respective strategic agendas   Transaction subject to agreement
sell its 40% shareholding in Glanbia                                                of binding legal contracts
Ireland                                     Proceeds will be deployed on growth
                                            and shareholder returns

Glanbia Ireland is 60% owned by             PLC will focus on driving sustainable   Transaction subject to shareholder
Glanbia Co-op and 40% by the PLC            growth in nutrition through its two     approvals. Expected completion
                                            growth platforms of GPN and GN          H1 2022
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
Glanbia
Performance
Nutrition
Q3 2021 review
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
7
Glanbia plc | Quarter 3 2021 presentation

GPN Q3 YTD 2021 update
                                                                                                                                      +25.2%
                                            Q3 YTD 2021 Revenue Progression, cc
    25%
                                                                                     0.8%

                                                                                                Americas
    20%                                                      4.4%
                                                                                                • Strong performance driven by Optimum Nutrition
                                                                                                • Price increase implemented during Q3
    15%                                                                                         • Ongoing headwinds in Diet category
                                                                                                International
                                                                                                • ASPAC and Middle East very strong performance
    10%
                                  18.0%                                                         • European markets and DTC performing well
                                                                                                • GPN Transformation has facilitated revenue growth
                                                                                                  management, route-to-market optimisation and brand focus
    5%
                                                                                                  during the year

    0%
                                 Volume                      Price                Acquisition

“cc” denotes constant currency
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
8
Glanbia plc | Quarter 3 2021 presentation

Leading brands positioned for growth

Brand health                                                                                                                Brand health
•      12 week consumption to 3 October 2021 in NA                                                                          •     12 week consumption to 3 October 2021 in NA measured
       measured channels* +18.6%                                                                                                  channels* -8.8%

Category update                                                                                                             Category update
•      Strong performance across all channels                                                                               •     Covid headwinds in Diet category
•      Expanding into new consumer occasions                                                                                •     Focused on brand activation and innovation

*North America measured channels include Online, FDMC (Food, Drug, Mass, Club) and Specialty channels. Date provided is for L12 weeks to 3 October 2021
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
Glanbia
Nutritionals
Q3 2021 review
Glanbia plc Q3 2021 10 November 2021 - Group Managing Director Group Finance Director
10
Glanbia plc | Quarter 3 2021 presentation

Glanbia Nutritionals Q3 2021 update

                                            Q3 2021 Revenue Progression, cc
  20%

  16%
                                                                                            Volume
                                                           (6.6%)                           • Strong customer demand across all business
                                                                                              segments
  12%                                                                            1.0%       Price
                                                                                            • Price related to lower year-on-year cheese markets
                                   18.2%
     8%                                                                                     Acquisition

     4%                                                                                     •   ‘PacMoore’ is a US food manufacturer specialising
                                                                                                in protein applications, including texturisation
                                                                                            •   The acquisition will enhance NS’s growth in the
     0%                                                                                         healthy snacking solutions category
                                 Volume                    Price              Acquisition   •   Purchase price of $52 million

“cc” denotes constant currency
11
Glanbia plc | Quarter 3 2021 presentation

Nutritional Solutions Q3 2021 update
                                                                                                                                    +15.7%

                                            Q3 2021 Revenue Progression, cc
  20%
                                                                                 3.3%
                                                                                            Volume
                                                           1.9%                             • Strong volume performance in micro-nutrients and
  15%                                                                                         healthy snacking solutions
                                                                                            • Consumer trends accelerating demand
                                                                                            Price
  10%
                                                                                            • Driven by healthy snacking solutions
                                                                                            • Strong demand for underlying dairy ingredients
                                   15.7%
                                                                                            Acquisitions
     5%                                                                                     •   Foodarom and PacMoore performing well

     0%
                                 Volume                    Price              Acquisition

“cc” denotes constant currency
12
Glanbia plc | Quarter 3 2021 presentation

US Cheese Q3 2021 update

                                            Q3 2021 Revenue Progression, cc
  20%
                                                                                   Volume
                                                                                   • Q3 volumes driven by new Joint Venture capacity fully
  16%
                                                                                     commissioned during the year
                                                                         (10.1%)

  12%                                                                              Price
                                                                                   • Price decline driven by lower cheese markets
                                            19.3%
     8%

     4%

     0%
                                            Volume                        Price

“cc” denotes constant currency
Finance
Q3 2021 review
14
Glanbia plc | Quarter 3 2021 presentation

Strong Cash Flow and Balance Sheet
                                                 Q3 2021            Q3 2020
                                                                                                  Cash
     Net Debt                                      €589m              €628m                     generative

     Net debt: Adjusted
                                                    1.50X              1.95X
     EBITDA

•        Rolling 12 months operating cash flow well ahead of 80% target
                                                                                 Facilitating                Balance
•        Strong balance sheet facilitates investment capability
                                                                                 investment                   Sheet
                                                                                                             capacity
•        At Q3 2021 - Total committed facilities of €1.1 billion with earliest
         maturity January 2024
15
Glanbia plc | Quarter 3 2021 presentation

Capital Allocation

          Expect to invest in FY 21         Invested €84 million   In last 12 months   Policy
Conclusion
17
Glanbia plc | Quarter 3 2021 presentation

Conclusions

                                        Good revenue momentum in Q3 2021 with trends continuing into Q4

                                        Strategic initiatives on track and navigating inflation through
                                        pricing and efficiencies

                                        Strong balance sheet to fund growth

                                        Positive outlook; in FY 21 Adjusted EPS growth, constant currency,
                                        expected to be at the upper end of the 17% to 22% range
Questions
You can also read